Esprinet S.P.A. Announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was EUR 2,236.823 million compared to EUR 1,834.676 million a year ago. Operating income was EUR 34.059 million compared to EUR 14.612 million a year ago. Net income was EUR 22.128 million compared to EUR 7.813 million a year ago. Basic earnings per share from continuing operations was EUR 0.45 compared to EUR 0.16 a year ago. Diluted earnings per share from continuing operations was EUR 0.44 compared to EUR 0.16 a year ago.